Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (21)

  1. Erasmo Saucedo Uribe, Farid Carranza Navarro, Andrea Fernanda Guerrero Medrano, Karen Iscely García Cervantes, Neri Alejandro Álvarez Villalobos, Víctor Daniel Acuña Rocha, Mauricio Méndez Hernández, Juan Manuel Millán Alanís, César Marcelo Hinojosa Cavada, Jorge Alberto Zúñiga Hernández, Stefan Mauricio Fernández Zambrano. Preliminary efficacy and tolerability profiles of first versus second-generation Long-Acting Injectable Antipsychotics in schizophrenia: A systematic review and meta-analysis. Journal of Psychiatric Research 2020;129:222
    https://doi.org/10.1016/j.jpsychires.2020.06.013
  2. Shen-Chieh Chang, Kah Kheng Goh, Mong-Liang Lu. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. WJP 2021;11:696
    https://doi.org/10.5498/wjp.v11.i10.696
  3. WonKyung Cho, Won-Suk Shin, Iseul An, Minji Bang, Doo-Yeoun Cho, Sang-Hyuk Lee. Biological Aspects of Aggression and Violence in Schizophrenia. Clin Psychopharmacol Neurosci 2019;17:475
    https://doi.org/10.9758/cpn.2019.17.4.475
  4. Lulu Lian, David D. Kim, Ric M. Procyshyn, Diane H. Fredrikson, Diana Cázares, William G. Honer, Alasdair M. Barr. Efficacy of long‐acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta‐analysis. Early Intervention in Psychiatry 2021
    https://doi.org/10.1111/eip.13202
  5. Vanteemar S. Sreeraj, Venkataram Shivakumar, Naren P. Rao, Ganesan Venkatasubramanian. Long-Acting Drug Delivery Systems. 2021.
    https://doi.org/10.1016/B978-0-12-821749-8.00009-4
  6. Charmi Patel, Bruno Emond, Marie-Hélène Lafeuille, Aurélie Côté-Sergent, Patrick Lefebvre, Neeta Tandon, Antoine C. El Khoury. Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate. Drugs - Real World Outcomes 2020;7:19
    https://doi.org/10.1007/s40801-019-00172-9
  7. Luisa Peters, Amanda Krogmann, Laura von Hardenberg, Katja Bödeker, Viktor B. Nöhles, Christoph U. Correll. Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016–March 2019. Curr Psychiatry Rep 2019;21
    https://doi.org/10.1007/s11920-019-1114-0
  8. Kai-Chun Yang, Yin-To Liao, Yen-Kuang Yang, Shih-Ku Lin, Chih-Sung Liang, Ya-Mei Bai. Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN). CNS Drugs 2021;35:893
    https://doi.org/10.1007/s40263-021-00838-5
  9. Miquel Bernardo, Fernando Rico-Villademoros, Clemente García-Rizo, Rosa Rojo, Ricardo Gómez-Huelgas. Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies. Adv Ther 2021;38:2491
    https://doi.org/10.1007/s12325-021-01689-8
  10. Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, Lucas Roberto Moreira, Fernanda Fiel Peres, Antonio Waldo Zuardi, José Alexandre Crippa, Jaime Eduardo Cecilio Hallak, Vanessa Costhek Abílio. Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?. Front. Pharmacol. 2021;11
    https://doi.org/10.3389/fphar.2020.635763
  11. Nisha Pippal, Sumita Halder, Shruti Srivastava, Rajarshi Kar, Rachna Gupta, Almeida Edelbert Anthonio. Correlation between telomere length and efficacy of oral and long-acting injectable antipsychotics on severity and cognitive impairment of schizophrenia. International Journal of Psychiatry in Clinical Practice 2021:1
    https://doi.org/10.1080/13651501.2021.1994613
  12. Seon-Cheol Park, Hong Seok Oh, Adarsh Tripathi, Roy Abraham Kallivayalil, Ajit Avasthi, Sandeep Grover, Andi Jayalangkara Tanra, Shigenobu Kanba, Takahiro A. Kato, Toshiya Inada, Kok Yoon Chee, Mian-Yoon Chong, Shih-Ku Lin, Kang Sim, Yu-Tao Xiang, Chay Hoon Tan, Afzal Javed, Norman Sartorius, Naotaka Shinfuku, Yong Chon Park. Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia. Nordic Journal of Psychiatry 2019;73:323
    https://doi.org/10.1080/08039488.2019.1632381
  13. Juan J. Fernández-Miranda, Silvia Díaz-Fernández, Francisco López-Muñoz. Adherence, Tolerability and Effective Doses of Aripiprazole Once-monthly in the Long-term Treatment of Patients with Severe Schizophrenia. CPD 2021;27:4078
    https://doi.org/10.2174/1381612827666210701160013
  14. Juan J. Fernández-Miranda, Silvia Díaz-Fernández, Francisco López-Muñoz. Oral Versus Long-Acting Injectable Antipsychotic Treatment for People With Severe Schizophrenia. J Nerv Ment Dis 2021;209:330
    https://doi.org/10.1097/NMD.0000000000001299
  15. Jhin Goo Chang, Daeyoung Roh, Chan-Hyung Kim. Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients. Clin Psychopharmacol Neurosci 2019;17:273
    https://doi.org/10.9758/cpn.2019.17.2.273
  16. P. Takács, P. Czobor, L. Fehér, J. Gimesi-Országh, P. Fadgyas-Freyler, M. Bacskai, P. Rakonczai, A. Borsi, R. Hegyi, T. Németh, J. Sermon, I. Bitter, Vincenzo De Luca. Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary. PLoS ONE 2019;14:e0218071
    https://doi.org/10.1371/journal.pone.0218071
  17. Mary V. Seeman. The Gut Microbiome and Treatment-Resistance in Schizophrenia. Psychiatr Q 2020;91:127
    https://doi.org/10.1007/s11126-019-09695-4
  18. Omran Davarinejad, Tahereh Mohammadi Majd, Farzaneh Golmohammadi, Payam Mohammadi, Farnaz Radmehr, Mostafa Alikhani, Tayebeh Motaei, Mehdi Moradinazar, Annette Brühl, Dena Sadeghi Bahmani, Serge Brand. Identification of Risk Factors to Predict the Occurrences of Relapses in Individuals with Schizophrenia Spectrum Disorder in Iran. IJERPH 2021;18:546
    https://doi.org/10.3390/ijerph18020546
  19. Kimberly K. Scarsi, Susan Swindells. The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?. J Int Assoc Provid AIDS Care 2021;20:232595822110090
    https://doi.org/10.1177/23259582211009011
  20. So-Young Oh, Duk-In Jon, Hyun Ju Hong, Narei Hong, Jung-Seo Yi, Daeyoung Roh, Myung Hun Jung. The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study. Clin Psychopharmacol Neurosci 2019;17:531
    https://doi.org/10.9758/cpn.2019.17.4.531
  21. José Manuel Olivares, Ana González-Pinto, Mario Páramo. Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. Eur. Psychiatr. 2021;64
    https://doi.org/10.1192/j.eurpsy.2021.23